Cardiac ischemia is a medical condition characterized by a reduction in blood flow to the heart muscle, typically resulting from the narrowing or blockage of coronary arteries. This diminished blood supply deprives the heart tissue of vital oxygen and nutrients, potentially causing damage or the death of affected cells. The consequences of cardiac ischemia extend to the development of various heart-related issues, including angina and myocardial infarction (heart attack). Recognizable symptoms encompass chest pain or discomfort, shortness of breath, and fatigue. Prompt diagnosis and intervention are essential to effectively manage cardiac ischemia, preventing more severe complications and promoting overall heart health. Treatment approaches may involve lifestyle modifications, medications, and, when necessary, medical procedures tailored to address and alleviate the impacts of cardiac ischemia. Regular monitoring and close collaboration with healthcare professionals play a pivotal role in the successful management of this condition.
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States